SEI Medical PCL (BKK:SEI)
Thailand · Delayed Price · Currency is THB 2.000
0.00 (0.00%)
At close: May 8, 2026
SEI Medical PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 449.68 | 443.98 | 393.57 | 320.55 | 375.73 |
Other Revenue | - | - | - | - | 2.47 |
| 449.68 | 443.98 | 393.57 | 320.55 | 378.2 | |
Revenue Growth (YoY) | 1.28% | 12.81% | 22.78% | -15.24% | 0.14% |
Cost of Revenue | 293.41 | 289.66 | 277.26 | 219.11 | 266.41 |
Gross Profit | 156.26 | 154.32 | 116.31 | 101.44 | 111.79 |
Selling, General & Admin | 98.75 | 89.11 | 86.38 | 78.17 | 61.84 |
Other Operating Expenses | -1.43 | -1.36 | - | - | 25.29 |
Operating Expenses | 97.32 | 87.75 | 86.38 | 78.17 | 87.13 |
Operating Income | 58.94 | 66.57 | 29.93 | 23.27 | 24.66 |
Interest Expense | -2.16 | -3.34 | -3.29 | -2.78 | -3.14 |
Interest & Investment Income | 1.69 | 2.07 | 0.82 | 0.04 | 0.01 |
Currency Exchange Gain (Loss) | - | - | - | - | -1.42 |
Other Non Operating Income (Expenses) | - | - | 0.01 | 0.28 | - |
EBT Excluding Unusual Items | 58.47 | 65.3 | 27.48 | 20.81 | 20.1 |
Gain (Loss) on Sale of Assets | - | - | 0.01 | 1.77 | 1.68 |
Asset Writedown | - | - | - | - | -0.01 |
Pretax Income | 58.47 | 65.3 | 27.49 | 22.59 | 21.78 |
Income Tax Expense | 11.97 | 13.07 | 5.62 | 4.72 | 6.34 |
Net Income | 46.5 | 52.23 | 21.87 | 17.86 | 15.44 |
Net Income to Common | 46.5 | 52.23 | 21.87 | 17.86 | 15.44 |
Net Income Growth | -10.97% | 138.82% | 22.43% | 15.73% | -46.39% |
Shares Outstanding (Basic) | 170 | 134 | 120 | 100 | 12 |
Shares Outstanding (Diluted) | 170 | 134 | 120 | 100 | 12 |
Shares Change (YoY) | 26.67% | 12.09% | 19.48% | 735.07% | - |
EPS (Basic) | 0.27 | 0.39 | 0.18 | 0.18 | 1.29 |
EPS (Diluted) | 0.27 | 0.39 | 0.18 | 0.18 | 1.29 |
EPS Growth | -29.72% | 113.05% | 2.47% | -86.14% | -46.39% |
Free Cash Flow | 37.25 | 39.64 | -29.95 | 34.55 | - |
Free Cash Flow Per Share | 0.22 | 0.29 | -0.25 | 0.34 | - |
Dividend Per Share | 0.110 | 0.120 | - | 41.670 | - |
Dividend Growth | -8.33% | - | - | - | - |
Gross Margin | 34.75% | 34.76% | 29.55% | 31.65% | 29.56% |
Operating Margin | 13.11% | 14.99% | 7.61% | 7.26% | 6.52% |
Profit Margin | 10.34% | 11.76% | 5.56% | 5.57% | 4.08% |
Free Cash Flow Margin | 8.28% | 8.93% | -7.61% | 10.78% | - |
EBITDA | 71.33 | 77.39 | 41.81 | 36.58 | - |
EBITDA Margin | 15.86% | 17.43% | 10.62% | 11.41% | - |
D&A For EBITDA | 12.39 | 10.82 | 11.87 | 13.31 | - |
EBIT | 58.94 | 66.57 | 29.93 | 23.27 | 24.66 |
EBIT Margin | 13.11% | 14.99% | 7.61% | 7.26% | 6.52% |
Effective Tax Rate | 20.47% | 20.01% | 20.43% | 20.91% | 29.12% |
Revenue as Reported | 449.68 | 443.98 | 393.57 | 320.55 | 379.9 |
Advertising Expenses | - | - | - | - | 0.7 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.